Lovable vs NEURONwriter affiliate programs
Lovable is an AI code tool and NEURONwriter is an AI SEO tool. Both run affiliate programs. Lovable lists 20%; NEURONwriter lists 30% on every payment. One of the two does not state a cookie window, so the attribution windows cannot be compared. aifilliate records each program from a cited vendor source and does not rank the two.
These are not alternatives to each other — Lovable is an AI code tool and NEURONwriter is an AI SEO tool. What follows compares their affiliate terms, not the products.
| Recorded term | Lovable Verified | NEURONwriter Verified |
|---|---|---|
| Commission | 20% | 30% on every payment |
| Structure | Recurring | Recurring |
| Cookie window | 60 days | Not stated |
| Network | Not stated | Not stated |
| Payout threshold | Not stated | Not stated |
| Terms checked | 2026-07-03 | 2026-08-20 |
| Source | Open source ↗ | Open source ↗ |
What matches, what differs
Differences
- Different categories: Lovable is an AI code tool, NEURONwriter is an AI seo tool.
In common
- Both pay recurring commission.
What is not published
Anything below has to be confirmed with the vendor before either offer can be modelled. aifilliate records it as unknown rather than estimating it.
- Neither vendor publishes a payout threshold or the platform running the program.
- NEURONwriter does not publish a cookie window.
How to read these two records
Both rates are stated as percentages of customer payments, so the figures share a basis. They may still cover different plans, billing terms, and eligibility rules.
Both pay recurring commission. One of the two does not state a cookie window, so the attribution windows cannot be compared.
aifilliate publishes no ranking between Lovable and NEURONwriter. Which program earns more depends on plan price, conversion rate, retention, and refund reversals in your own audience — none of which appear in published affiliate terms. Confirm eligibility, paid-search and trademark rules, and payout timing with each vendor before promoting either.